In order to accelerate progress towards attainment of international development goals and targets in sexual and reproductive health, and in particular to contribute to meeting unmet need for contraceptive information and services, WHO has published guidance for policy-makers, programme managers providers and other stakeholders in the health sector on how to ensure that human rights are respected, protected and fulfilled, while services are scaled up to reduce unmet need for contraception
Postpartum family planning
Postpartum family planning is the prevention of unintended and closely spaced pregnancies through the first 12 months following childbirth. Providers, women, their families and communities, as well as policy-makers and programme managers, often do not think of the need for family planning at this time. They may not be aware that a woman’s fertility can return in the early months after birth and that with timely initiation most contraceptive methods are safe for the breastfeeding mother. Providing contraception during this period is both cost-effective for health systems (as couples are generally already visiting the health facility) and for clients who avoid unnecessary return trips to the health-care facility.
WHO convened a series of technical consultations between 13 and 16 May 2013 in order to plan the updates of its evidence-based family planning guidelines. As part of the process for updating these guidelines, WHO will be considering the evidence related to VTE risk associated with oral contraceptive formulations with various progestogens. Once this process has been completed, WHO will be in a position to provide global guidance on this issue
Online curriculum components and tools to deliver family planning training
The Training Resource Package for Family Planning (TRP) is a set of materials designed to support training on family planning and reproductive health (FP/RH). The tools can be used by facilitators and curriculum developers to design, implement and evaluate high-quality training and education in FP/RH. The development has been by led by WHO, UNFPA, USAID and other partners and agencies.